MNTL Tema Neuroscience And Mental Health ETF
The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.
No price history on file.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| MNTL | +0.0% | +5.0% | -3.3% | -10.7% | -2.3% | -1.4% |
| Equity average (4622 funds) | -2.1% | +2.7% | +87.7% | +61233.4% | +13.9% | +2.3% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$316K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| RAPP RAPPORT THERAPEUTICS, INC. | 0.21% | $22.0M | $4.5M |
| SRRK SCHOLAR ROCK HOLDING CORP. | 1.71% | $12.0M | $0 |
| PRTA PROTHENA CORP. PLC | 0.42% | $9.8M | $0 |
| XENE XENON PHARMACEUTICALS, INC. | 1.81% | $1.7M | $426K |
| ALNY ALNYLAM PHARMACEUTICALS, INC. | 7.74% | $543K | $399K |
| DYN DYNE THERAPEUTICS, INC. | 0.46% | $40K | $248K |
Holdings · as of Aug 5, 2025
| # | Holding | Weight |
|---|---|---|
| 1 | VRTX VERTEX PHARMACEUTICALS, INC. | 10.33% |
| 2 | REGN REGENERON PHARMACEUTICALS, INC. | 8.09% |
| 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | 7.74% |
| 4 | ARGX ARGENX SE | 5.83% |
| 5 | NBIX NEUROCRINE BIOSCIENCES, INC. | 4.89% |
| 6 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD. | 4.32% |
| 7 | LLY ELI LILLY & CO. | 4.05% |
| 8 | CRNX CRINETICS PHARMACEUTICALS, INC. | 3.54% |
| 9 | IONS IONIS PHARMACEUTICALS, INC. | 3.48% |
| 10 | SYK STRYKER CORP. | 3.22% |
| 11 | BIIB BIOGEN, INC. | 3.21% |
| 12 | MDT MEDTRONIC PLC | 2.59% |
| 13 | UCB.BR UCB SA | 2.48% |
| 14 | ACAD ACADIA PHARMACEUTICALS, INC. | 2.42% |
| 15 | CPRX CATALYST PHARMACEUTICALS, INC. | 2.33% |
| 16 | AXSM AXSOME THERAPEUTICS, INC. | 2.33% |
| 17 | CASH & CASH EQUIVALENTS | 2.08% |
| 18 | DNLI DENALI THERAPEUTICS, INC. | 1.98% |
| 19 | RNA AVIDITY BIOSCIENCES, INC. | 1.88% |
| 20 | JAZZ JAZZ PHARMACEUTICALS PLC | 1.88% |
| 21 | XENE XENON PHARMACEUTICALS, INC. | 1.81% |
| 22 | DXCM DEXCOM, INC. | 1.72% |
| 23 | SRRK SCHOLAR ROCK HOLDING CORP. | 1.71% |
| 24 | PTCT PTC THERAPEUTICS, INC. | 1.58% |
| 25 | ALKS ALKERMES PLC | 1.53% |
| 26 | PEN PENUMBRA, INC. | 1.46% |
| 27 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 1.44% |
| 28 | OPCH OPTION CARE HEALTH, INC. | 1.37% |
| 29 | SHL.DE SIEMENS HEALTHINEERS AG | 1.30% |
| 30 | ORNBV.HE ORION OYJ | 1.14% |
| 31 | IMVT IMMUNOVANT, INC. | 0.90% |
| 32 | NTLA INTELLIA THERAPEUTICS, INC. | 0.86% |
| 33 | TALK TALKSPACE, INC. | 0.63% |
| 34 | SLDB SOLID BIOSCIENCES, INC. | 0.57% |
| 35 | PRAX PRAXIS PRECISION MEDICINES, INC. | 0.55% |
| 36 | BHVN BIOHAVEN LTD. | 0.55% |
| 37 | ACHC ACADIA HEALTHCARE CO., INC. | 0.53% |
| 38 | DYN DYNE THERAPEUTICS, INC. | 0.46% |
| 39 | VYGR VOYAGER THERAPEUTICS, INC. | 0.43% |
| 40 | PRTA PROTHENA CORP. PLC | 0.42% |
| 41 | RAPP RAPPORT THERAPEUTICS, INC. | 0.21% |
| 42 | ARVN ARVINAS, INC. | 0.15% |
Sector breakdown
Not on file.
Country breakdown
Not on file.
Distributions
| Date | Per unit |
|---|---|
| Dec 11, 2024 | $0.2570 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in MNTL in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error